Coronary no-reflow and adverse events in patients with acute myocardial infarction after percutaneous coronary intervention with current drug-eluting stents and third-generation P2Y12 inhibitors
ConclusionIn patients with AMI undergoing PCI with current DES and third generation P2Y12 receptor inhibitors, CNR was associated with a higher risk of adverse outcomes at 1 year.Graphical abstract
Source: Clinical Research in Cardiology - Category: Cardiology Source Type: research
More News: Angioplasty | Bleeding | Cardiology | Coronary Angioplasty | Heart | Heart Attack | Percutaneous Coronary Intervention | Stroke | Study